IndyGeneUS AI is a genomics company building a digital blockchain-encrypted bio-bank.
IndyGeneUS AI has raised $50K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2022.
IndyGeneUS AI's investors include Johnson & Johnson, IsimoVest Venture Capital Partners, Merck Global Health Innovation Fund, Voltron Capital, Johnson & Johnson Robotics and Digital Solutions.
IndyGeneUS AI is headquartered in Washington, United States.
IndyGeneUS AI is a genomics company building a digital blockchain-encrypted bio-bank.
IndyGeneUS AI is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IndyGeneUS AI — Funding & Investors." VCBacked, December 16, 2022, https://www.vcbacked.co/company/indygeneus-ai. Accessed August 14, 2026.
VCBacked. (2022). IndyGeneUS AI — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/indygeneus-ai
{{cite web |title=IndyGeneUS AI — Funding & Investors |url=https://www.vcbacked.co/company/indygeneus-ai |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated